Neuropathology of epileptic encephalopathies and non-paroxysmal epileptic disorders and principles of their treatment
https://doi.org/10.14412/2074-2711-2010-80
Abstract
Based on his many year's studies and the data available in the literature, the author considers the neuropathophysiological mechanisms responsible for the damaging action of epileptic discharges on basic brain functions and provides evidence for the views of prolonged non-paroxysmal psychoneurological epileptic disorders and epileptic encephalopathies. He shows the consistency of clinical manifestations of the site of cerebral epileptic discharges on the basis of an update on their functional localization and functional neuroimaging. Computerized three-dimensional electroencephalography (EEG) data mapping is shown to play a crucial role in the understanding of the mechanisms, diagnosis, and treatment of non-paroxysmal epileptic disorders. Based on the concepts that epileptiform activity plays a neuropathological role in the genesis of non-paroxysmal epileptic disorders, the author substantiates the use of agents that are effective in suppressing EEG epileptiform activity (valproate, levetiracetam, and lamotrigine) as a first-choice drug and caution when giving the antiepileptics that can aggravate epileptiform activity and clinical manifestations.
References
1. <div><p>Engel J. Jr. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia 2001; 42: 796-803.</p><p>Зенков Л.Р. Непароксизмальные эпилептические расстройства (руководство для врачей). М.: МЕДпресс-информ, 2007.</p><p>Зенков Л.Р. Эпилепический синдром нарушения развития правого полушария. Неврол. журн. 2007; 12(1): 29-33.</p><p>Зенков Л.Р. Непароксизмальные психические и поведенческие нарушения, связанные с билатерально-синхронными эпилептиформными разрядами в ЭЭГ (анализ собственных случаев и обзор литературы). Неврол. журн. 2009; 14(5): 22-7.</p><p>Зенков Л.Р., Шевельчинский С.И., Константинов П.А. и др. Бессудорожные эпилептические энцефалопатии, аутизм и другие растрой- ства психического развития. Аутизм и нарушения развития 2004; 1: 2-19.</p><p>Chez M., Buchanon C. Age of regression of language and behaviour in children referred for pervasive developmental delay correlate to severity of epileptiform activity on 24 hour EEG. Epilepsia 1997; 38(Suppl. 3): 50.</p><p>Deckel A.W., Hesselbrock V., Bauer L. Antisocial personality disorder, childhood delinquency, and frontal brain functioning: EEG and neuropsychological findings. J Clin Psychol 1996; 52: 639-50.</p><p>Eriksson K., Kylliainen A., Hirvonen K. et al. Visual agnosia with occipital CSWS-A Landau- Kleffner equivalent? Epilepsia 2000; 41(Suppl. 7): 195.</p><p>Kutschke G., Brodbeck V., Boor R., Reitter B. Do subclinical epileptic discharges (SED) influence language functions in children with developmental language disorder (DLD)? Epilepsia 1999; 40(Suppl. 2): 20.</p><p>Мельничук П.В., Зенков Л.Р., Морозов А.А. и др. Нейрофизиологические механизмы афазии при эпилепсии. Журн. невропатол. и психиатр. 1990; 90: 34-40.</p><p>Blakemore S.J. The social brain in adolescence. Nat Rev Neurosci 2008; 9: 267-77.</p><p>Paquier P.F., Verheulpen D., De Tiege X., Van Bogaert P. Acquired cognitive dysfunction with focal sleep spiking activity. Epilepsia 2009; 50(Suppl. 7): 29-32.</p><p>Perez E.R., Davidoff V., Despland P.A., Deonna T. Mental and behavioural deterioration of children with epilepsy and CSWS: acquired epileptic frontal syndrome. Dev Med Child Neurol 1993; 35: 661-74.</p><p>Taneli B. Epileptic phenomena underlying psychiatric disorders: schizophrenic disorder, affective and anxiety disorder. Epileptologia 2001; 9(Suppl. 1): 18-9.</p><p>Heath R.G. Common clinical characteristics of epilepsy and schizophrenia: clinical observation and depth electrode studies. Am J Psychiatry 1962; 118: 1013-26.</p><p>Мirsky A.F., Duncan C.C., Levav M.L. Neuropsychological and psychophysiolgical aspects of absence epilepsy. In: J.S. Duncan, C.P. Panayiotopoulos (eds). Typical absence and related epileptic syndromes. Edinburgh: Churchill Livingstone 1995; 112-21.</p><p>Daffner K.R., Mesulam M.M., Scinto L.F.M. et al. The central role of the prefrontal cortex in directing attention to novel events. Brain 2000; 123: 927-39.</p><p>Зенков Л.Р., Константинов П.А., Мясников В.Н. и др. Бессудорожные эпилептические энцефалопатии и их лечение. Журн. неврол. и психиатр. им. С.С. Корсакова 2004; 104: 30-8.</p><p>Kawasaki Y., Yokota K., Shinomiya M. et al. Electroencephalographic paroxysmal activities in the frontal area emerged in middle childhood and during adolescence in a follow-up study of autism. J Autism Develop Disord 1997; 27: 605-20.</p><p>Lewine J.D., Andrews R., Chez M. et al. Magnetoencephalographic patterns of epileptiform activity in children with regressive autism spectrum disorders. Pediatrics 1999; 104: 405-18.</p><p>Thomas P., Zifkin B., Migneco O. et al. Nonconvulsive status epilepticus of frontal origin. Neurology 1999; 52: 1174.</p><p>Tuchman R.F., Rapin I. Regression in pervasive developmental disorders: seizures and epileptiform electroencephalogram correlates. Pediatrics 1997; 99: 560-6.</p><p>Iivanainen M., Bergstrom L., Nuutila A., Viukari M. Psychosis-like absence status of elderly patients: successful treatment with sodium valproate. J Neurol Neurosurg Psych 1984; 47: 965-9.</p><p>Kramer U., Sagi L., Goldberg-Stern H. et al. Clinical spectrum and medical treatment of children with electrical status epilepticus in sleep (ESES). Epilepsia 2009; 50: 1517-24.</p><p>Miller J.W., Yanagihara T., Petersen R.C., Klass D.W. Transient global amnesia and epilepsy: electroencephalographic distinction. Arch Neurol 1987; 4: 629-33.</p><p>Garcia-Flores E. Corpus callosotomy for the treatment of Landau-Kleffner syndrome. Epilepsia 1999; 40(Suppl. 2): 62.</p><p>Grote C.L., Van Slyke P., Hoeppner J.A. Language outcome following multiple subpial transection for Landau Kleffner syndrome. Brain 1999; 122: 561-6.</p><p>Childs J.A., Blair J.L. Valproic acid treatment of epilepsy in autistic twins. J Neurosci Nurs 1997; 29: 244-8.</p><p>Plioplys A.V. Autism: electroencephalogram abnormalities and clinical improvement with valproic acid. Arch Pediatr Adolesc Med 1994; 148: 220-2.</p><p>Geaney D. Clozapine can cause hallucinations by inducing complex partial seizures of temporal lobe origin (temporal lobe epilepsy). A potentially serious complication in the management of schizophrenia with clozapine. J Psychopharmacol 1995; 9: 64-6.</p><p>Hilty D.M., Rodriguez G.D., Hales R.E. Treatment of comorbid bipolar disorder and epilepsy with valproate. J Neuropsychiatry Clin Neurosci 2000; 12: 283-5.</p><p>Zenkov L.R., Konstantinov P.A., Shiriayeva I.U. et al. Benign epileptiform discharges of childhood: are they benign? Epileptologia 2005; 13(Suppl. 1): 105.</p><p>Dulac O. Epileptic encephalopathy. Epilepsia 2001; 42(Suppl. 3): 23-6.</p><p>Weglage J., Demsky A., Pietsch M., Kurlemann G. Neuropsychological, intellectual, and behavioral findings in patients with centrotemporal spikes with and without seizures. Dev Med Child Neurol 1997; 39: 646-51.</p><p>Barbaresi W.J., Katusic S.K., Voigt R.G. Autism: A Review of the State of the Science for Pediatric Primary Health Care Clinicians. Arch Pediatr Adolesc Med 2006; 160: 1167-75.</p><p>Nass R., Gross A., Devinsky O. Autism and autistic epileptiform regression with occipital spikes. Dev Med Child Neurol 1998; 40: 453-8.</p><p>O'Regan M.E., Brown J.K., Goodwin G.M., Clarke M. Epileptic aphasia: a consequence of regional hypometabolic encephalopathy? Dev Med Child Neurol 1998; 40: 508-16.</p><p>Зенков Л.Р. Противосудорожная терапия может утяжелять течение эпилепсии. Неврол. журн. 2007; 12(3): 8-13.</p><p>Ben-Ari Y. Cell death and synaptic reorganization produced by seizures. Epilepsia 2001; 42(Suppl. 3): 5-7.</p><p>Scharfman H.E., Goodman J.H., Sollas A.L. Granule-like neurons at the hilar/CA3 border after status epilepticus and their synchrony with area CA3 pyramidal cells: functional implications of seizure-induced neurogenesis. J Neurosci 2000; 20: 6144-58.</p><p>Зенков Л.Р. Клиническое значение изменений электроэнцефалограммы при лечении эпилепсии вальпроатом (Депакин хроно). Журн. неврол. и психиатр. им. С.С. Корсакова 2002; 102: 20-6.</p><p>Зенков Л.Р. Место вальпроатов (Депакин) в фармакотерапии эпилепсии XXI века. Рус. мед. журн. 2009; 17(9): 1-7.</p><p>Binnie C.D. Significance and management of transitory cognitive impairment due to subclinical EEG discharges in children. Brain Dev 1993; 15: 23-30.</p><p>Hendriks M.P.H., Scholtes F.B.J. Neuropsychological profiles of 11 children with continuous spikes and waves during sleep (CSWS); a clinical follow-up. Epilepsia 1999; 40(Suppl. 2): 165.</p><p>Khatami R., Grosse P., Hoffmann K.-T. et al. Treatment of nonconvulsive status epilepticus with topiramate. Epilepsia 1999; 40(Suppl. 2): 285.</p><p>Pressler R.O., Robinson R.O., Wilson G.A., Binnie C.D. Treatment of interictal epileptiform discharges can improve behavior in children with behavioral problems and epilepsy. J Pediatr 2005; 146: 112-7.</p><p>Romero-Andujar F.A., Garcia-Penas J.J., Ruiz-Falco M.L. et al. Efficacy of levetiraceram in pharmacoresistant continuous spike-wave activity during slow sleep. Epilepsia 2005; 46(Suppl. 6): 268-9.</p><p>Stefanatos G.A., Grover W., Geller E. Case study: corticosteroid treatment of language regression in pervasive developmental disorder. J Acad Child Adolesc Psychiatry 1995; 34: 1107-87.</p><p>Seidel W.T., Mitchell W.G. Cognitive and behavioral effects of carbamazepine in children: data from benign rolandic epilepsy. J Child Neurol 1999; 14: 716-23.</p><p>Vendrame M., Khurana D.S., Cruz M. et al. Aggravation of seizures and/or EEG features in children treated with oxcarbazepine monotherapy. Epilepsia 2007; 48: 2116-20.</p><p>Citrome L., Jaffe A., Levine L. et al. Datapoints: use of mood stabilizers among patients with schizophrenia, 1994-2001. Psychiatr Serv 2002; 53: 1212.</p><p>Yuan P.-X., Huang L.-D., Jiang Y.-M. et al. The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth. J Biol Chem 2001; 276: 31674-83.</p><p>Зенков Л.Р. Кеппра в лечении эпилепсии. М.: Пресс-сервис, 2007.</p><p>Зенков Л.Р. Изменения ЭЭГ в процессе лечения эпилепсии леветирацетамом (кеппра). Журн. неврол. и психиатр. 2009; 11(Вып. 2): 70-7.</p><p>Gross-Tsur V., Shalev R.S. Reversible language regression as an adverse effect of topiramate treatment in children. Neurology 2004; 62: 299-300.</p><p>Guerrini R., Belmonte A., Genton P. Antiepileptic drug-induced worsening of seizures in children. Epilepsia 1998; 39(Suppl. 3): 2-10.</p><p>Wieser H.G., Hailemariam S., Regard M., Landis T. Unilateral limbic epileptic status activity: stereo EEG, behavioral, and cognitive data. Epilepsia 1985; 26: 19-29.</p></div><br />
Review
For citations:
Zenkov LR. Neuropathology of epileptic encephalopathies and non-paroxysmal epileptic disorders and principles of their treatment. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2010;2(2):26-32. (In Russ.) https://doi.org/10.14412/2074-2711-2010-80
Views:
1063
Email this article 